Sfoglia per Autore
Prognostic Factors in Patients with Locally Advanced Cervical Cancer Treated with Radical Hysterectomy and Adjuvant Radiotherapy
1998 L. Frigerio, A. Mariani, L. Gandini, M. Origoni, L. Galli, E. Rabaiotti, G. Aletti, A. Ferrari
Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance
1999 C.F.M. Sier, N. Sidenius, A. Mariani, G. Aletti, V. Agape, A. Ferrari, G. Casetta, R.W. Stephens, N. Brünner, F. Blasi
Concomitant radiotherapy and paclitaxel for high-risk endometrial cancer: First feasibility study
2001 L. Frigerio, G. Mangili, G. Aletti, M. Carnelli, E. Garavaglia, S. Beatrice, A. Ferrari
Integrated FDG PET/CT in patients with persistent ovarian cancer: Correlation with histologic findings
2004 S. Sironi, C. Messa, G. Mangili, B. Zangheri, G. Aletti, E. Garavaglia, R. Vigano, M. Picchio, G. Taccagnai, A.D. Maschio, F. Fazio
Metabolism of tumour-derived urokinase receptor and receptor fragments in cancer patients and xenografted mice
2004 C.F.M. Sier, I. Nicoletti, M.L. Santovito, T. Frandsen, G. Aletti, A. Ferrari, A. Lissoni, R. Giavazzi, F. Blasi, N. Sidenius
Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis
2005 G. Mangili, G. Aletti, L. Frigerio, M. Franchi, N. Panacci, R. Viganò, P. De Marzi, F. Zanetto, A. Ferrari
Is aggressive surgery beneficial only for patients with less advanced ovarian cancer? A commentary on the international comparison within the SCOTROC-1 trial
2006 G.D. Aletti, W.A. Cliby
Serine protease HtrA1 modulates chemotherapy-induced cytotoxicity
2006 J. Chien, G. Aletti, A. Baldi, V. Catalano, P. Muretto, G.L. Keeney, K.R. Kalli, J. Staub, M. Ehrmann, W.A. Cliby, Y.K. Lee, K.C. Bible, L.C. Hartmann, S.H. Kaufmann, V. Shridhar
Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer
2006 G.D. Aletti, S.C. Dowdy, K.C. Podratz, W.A. Cliby
Is it justified to classify patients to Stage IIIC epithelial ovarian cancer based on nodal involvement only?
2006 W.A. Cliby, G.D. Aletti, T.O. Wilson, K.C. Podratz
Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon
2006 G.D. Aletti, B.S. Gostout, K.C. Podratz, W.A. Cliby
Aggressive surgical effort and improved survival in advanced-stage ovarian cancer
2006 G.D. Aletti, S.C. Dowdy, B.S. Gostout, M.B. Jones, C.R. Stanhope, T.O. Wilson, K.C. Podratz, W.A. Cliby
Role of lymphadenectomy in the management of grossly apparent advanced stage epithelial ovarian cancer
2006 G.D. Aletti, S. Dowdy, K.C. Podratz, W.A. Cliby
Importance of surgical aggressiveness in advanced ovarian cancer
2006 G.D. Aletti, W.A. Cliby
Role of Rectosigmoidectomy and Stripping of Pelvic Peritoneum in Outcomes of Patients with Advanced Ovarian Cancer
2006 G.D. Aletti, K.C. Podratz, M.B. Jones, W.A. Cliby
Corrigendum to "Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon" [Gynecol. Oncol. 100 (2006) 33-37]
2006 G.D. Aletti, B.S. Gostout, K.C. Podratz, W.A. Cliby
Surgical Management of Diaphragm Disease in Ovarian Cancer
2007 W. Cliby, G. Aletti
Epigenetic silencing of HSulf-1 in ovarian cancer: Implications in chemoresistance
2007 J. Staub, J. Chien, Y. Pan, X. Qian, K. Narita, G. Aletti, M. Scheerer, L.R. Roberts, J.F. MOLINA PALMA, V. Shridhar
How relevant are ACOG and SGO guidelines for referral of adnexal mass?
2007 A.C. Dearking, G.D. Aletti, M.E. Mcgree, A.L. Weaver, M. Sommerfield, W.A. Cliby
Is time to chemotherapy a determinant of prognosis in advanced-stage ovarian cancer?
2007 G.D. Aletti, H.J. Long, K.C. Podratz, W.A. Cliby
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile